Company Filing History:
Years Active: 2010
Title: Katherine Whartenby: Innovator in Hematopoietic Stem Cell Research
Introduction
Katherine Whartenby is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of immunology through her innovative research and inventions. Her work focuses on the modulation of systemic immune responses, particularly through the transplantation of hematopoietic stem cells.
Latest Patents
Katherine Whartenby holds a patent for her invention titled "Modulation of systemic immune responses by transplantation of hematopoietic stem cells transduced with genes encoding antigens and antigen presenting cell regulatory molecules." This invention provides methods and compositions for modulating immune responses using bi-cistronic lentiviral expression vectors. These vectors are designed for antigen expression in antigen presenting cells, which can be utilized in DNA vaccines targeting pathogens and tumor antigens, as well as for treating autoimmune diseases and establishing antigen tolerance. She has 1 patent to her name.
Career Highlights
Katherine is affiliated with The Johns Hopkins University, where she continues her research and development in the field of immunology. Her work has garnered attention for its potential applications in medical treatments and therapies.
Collaborations
Katherine has collaborated with notable colleagues, including Drew M Pardoll and Linzhao Cheng, who share her commitment to advancing research in hematopoietic stem cells and immune modulation.
Conclusion
Katherine Whartenby is a trailblazer in the field of immunology, with her innovative patent contributing to the understanding and treatment of immune-related conditions. Her work at The Johns Hopkins University and collaborations with esteemed colleagues further highlight her impact in this vital area of research.